Insulet Down Over 6%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
Oct 01

Insulet Corporation $(PODD)$ is currently at $289.49, down $19.24 or 6.23%

 

--Would be lowest close since Aug. 6, 2025, when it closed at $277.30

--On pace for largest percent decrease since Aug. 20, 2024, when it fell 6.87%

--Currently down eight of the past nine days

--Currently down seven consecutive days; down 13.62% over this period

--Longest losing streak since June 10, 2025, when it fell for seven straight trading days

--Worst seven day stretch since the seven days ending March 4, 2024, when it fell 14.87%

--Up 10.89% year-to-date

--Down 17.95% from its all-time closing high of $352.82 on Sept. 9, 2025

--Up 24.44% from 52 weeks ago (Oct. 2, 2024), when it closed at $232.63

--Down 17.95% from its 52-week closing high of $352.82 on Sept. 9, 2025

--Up 27.09% from its 52-week closing low of $227.79 on Oct. 7, 2024

--Traded as low as $289.49; lowest intraday level since Aug. 7, 2025, when it hit $286.68

--Down 6.23% at today's intraday low; largest intraday percent decrease since Sept. 10, 2025, when it fell as much as 6.47%

--Worst performer in the S&P 500 today

 

All data as of 10:46:24 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 01, 2025 10:48 ET (14:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10